Literature DB >> 25497908

Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.

Laia Valls1, Christopher Hoimes2, Andrew Sher1, Lingzhi Hu3, Zhenghong Lee1, Raymond Muzic1, Norbert Avril4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25497908     DOI： 10.1053/j.ro.2014.09.001

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN： 0037-198X            Impact factor:   0.800


× No keyword cloud information.
  3 in total

1.  Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response.

Authors:  Yulian Mytsyk; Serhiy Pasichnyk; Ihor Dutka; Ihor Dats; Dmytro Vorobets; Michał Skrzypczyk; Yerzhan Uteuliyev; Andrea Botikova; Katarina Gazdikova; Peter Kubatka; Peter Urdzik; Peter Kruzliak
Journal:  Clin Exp Med       Date:  2020-02-05       Impact factor: 3.984

Review 2.  ¹⁸F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.

Authors:  Stefanie Avril; Raymond F Muzic; Donna Plecha; Bryan J Traughber; Shaveta Vinayak; Norbert Avril
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

3.  Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study.

Authors:  Jacob Antunes; Satish Viswanath; Mirabela Rusu; Laia Valls; Christopher Hoimes; Norbert Avril; Anant Madabhushi
Journal:  Transl Oncol       Date:  2016-04       Impact factor: 4.243
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.